drugset / Trial / NCT01142310
Reversing Corticosteroid Induced Memory Impairment
Phase 4
Completed
54 enrolled
University of Texas Southwestern Medical Center
National Institute of Mental Health (NIMH) · collab
RandomizedParallel-groupQuadruple-blindHealth-services research
Summary
Medically stable outpatients receiving chronic oral corticosteroid therapy were enrolled in a 48-week randomized, double-blind, placebo-controlled, parallel-group, trial of lamotrigine.
Timeline
- Start
- 2010-06
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lamotrigine | Small molecule | 400 mg | Oral |